159 related articles for article (PubMed ID: 2484433)
21. The human interferon system.
Berman B; Frankfort HM
Int J Dermatol; 1982; 21(1):12-8. PubMed ID: 6174471
[No Abstract] [Full Text] [Related]
22. Chronic myelogenous leukemia--update and future directions.
Kantarjian HM; Deisseroth A; Talpaz M
Rev Invest Clin; 1994 Apr; Suppl():118-24. PubMed ID: 7886295
[No Abstract] [Full Text] [Related]
23. Interferon treatment of human neoplasia.
Strander H
Adv Cancer Res; 1986; 46():1-265. PubMed ID: 2425561
[No Abstract] [Full Text] [Related]
24. Clinical studies with interferons in Philadelphia positive chronic myelogenous leukemia.
Talpaz M; Kantarjian H; Kurzrock R; Gutterman JU
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():63. PubMed ID: 2496883
[No Abstract] [Full Text] [Related]
25. Clinical and biological activity of the interferons in hematologic malignancies.
Gutterman JU
Prog Clin Biol Res; 1989; 288():337-48. PubMed ID: 2470111
[No Abstract] [Full Text] [Related]
26. Interferons: current status and future directions of this prototypic biological.
Smalley RV; Borden EC
Springer Semin Immunopathol; 1986; 9(1):73-83. PubMed ID: 2425443
[No Abstract] [Full Text] [Related]
27. The therapy of multiple myeloma with the interferons.
Bonnem EM
Cancer Treat Rev; 1988 Jan; 15 Suppl A():35-41. PubMed ID: 2449280
[No Abstract] [Full Text] [Related]
28. Treatment with recombinant interferon-alpha-2C: multiple myeloma and thrombocythaemia in myeloproliferative diseases.
Ludwig H; Cortelezzi A; Van Camp BG; Polli E; Scheithauer W; Kuzmits R; Linkesch W; Gisslinger H; Sinzinger H; Fritz E
Oncology; 1985; 42 Suppl 1():19-25. PubMed ID: 4080297
[TBL] [Abstract][Full Text] [Related]
29. Interferon alpha-2a to control thrombocytosis in chronic myelogenous leukemia and essential thrombocythemia.
Jootar S
Asian Pac J Allergy Immunol; 1989 Dec; 7(2):103-5. PubMed ID: 2624663
[TBL] [Abstract][Full Text] [Related]
30. [Pathogenetic mechanisms of chronic myeloid leukemia and the antiproliferative effects of alpha and gamma interferons].
Cazzola M; Pedrazzoli P; Bergamaschi G; Buonanno C; Cuomo A; D'Uva R; Ponchio L; Rosti V; Zappone E; Ascari E
Haematologica; 1990; 75 Suppl 4():20-7. PubMed ID: 2127411
[No Abstract] [Full Text] [Related]
31. Assay of augmentation of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity by interferon.
Herberman RB; Ortaldo JR; Timonen T
Methods Enzymol; 1981; 79(Pt B):477-84. PubMed ID: 6173696
[No Abstract] [Full Text] [Related]
32. Biotherapy with interferon--1988.
Figlin RA
Semin Oncol; 1988 Dec; 15(6 Suppl 6):3-9. PubMed ID: 2462749
[TBL] [Abstract][Full Text] [Related]
33. The interferons in haematological malignancies.
Mandelli F; Arcese W; Avvisati G
Baillieres Clin Haematol; 1994 Mar; 7(1):91-113. PubMed ID: 7518713
[TBL] [Abstract][Full Text] [Related]
34. Biotherapy with interferon in hematologic malignancies.
Roth MS; Foon KA
Oncol Nurs Forum; 1987; 14(6 Suppl):16-22. PubMed ID: 2447569
[No Abstract] [Full Text] [Related]
35. Development and mechanisms of interferon resistance.
Kloke O; Niederle N
Cancer Treat Rev; 1990 Dec; 17 Suppl A():81-8. PubMed ID: 1709389
[No Abstract] [Full Text] [Related]
36. [Biological activity of human alpha-interferons studied using specific antisera].
Korsun NS; Nosik DN; Novokhatskiĭ AS; Trushinskaia GN
Antibiot Khimioter; 1988 Nov; 33(11):827-30. PubMed ID: 2465745
[TBL] [Abstract][Full Text] [Related]
37. Treatment of the myeloproliferative disorders with 32P.
Berlin NI
Eur J Haematol; 2000 Jul; 65(1):1-7. PubMed ID: 10914933
[TBL] [Abstract][Full Text] [Related]
38. Spectrum of biological activity of interferons.
Battistini A; Affabris E; Fiorucci G; Coccia EM; Romeo G; Marziali G; Rossi GB
Ann Ist Super Sanita; 1990; 26(3-4):227-53. PubMed ID: 1708952
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow transplantation for chronic myeloid leukaemia.
Goldman JM
Bone Marrow Transplant; 1991; 7 Suppl 2():62-3. PubMed ID: 1878724
[No Abstract] [Full Text] [Related]
40. Alpha interferon therapy for haematological malignancies: correlation between in vivo induction of the 2',5'oligoadenylate system and clinical response.
de Mel WC; Hoffbrand AV; Giles FJ; Goldstone AH; Mehta AB; Ganeshaguru K
Br J Haematol; 1990 Apr; 74(4):452-6. PubMed ID: 2346724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
